Company intelligence / Profile preview

Gryningsstunden Förvaltning

Stockholm, Stockholm, Sweden

Ownership: Private
Employees: ~1
Development stage: Other

Overview

AB Gryningsstunden Förvaltning is a Swedish private investment and holding company based in Stockholm, founded in 2016. The company primarily focuses on managing and investing in securities within the life sciences and biotechnology sectors, acting as a significant shareholder in clinical-stage firms such as Alligator Bioscience AB and ProstaLund AB. It is led by Johan Ranstam, a prominent biostatistician who represents the firm on the nomination committees of its portfolio companies. While the company does not maintain its own therapeutic pipeline, it provides strategic financial support and corporate governance expertise to the Nordic biotech ecosystem.

Industry: Investors

Beyond the preview

Go deeper on Gryningsstunden Förvaltning.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gryningsstunden Förvaltning.

Explore the full profile